Pricing Log in Create free account

Caribou Biosciences, Inc. (CRBU) vs LeonaBio, Inc. (LONA)

Caribou Biosciences, Inc. and LeonaBio, Inc. are both Biotechnology companies. Caribou Biosciences, Inc. and LeonaBio, Inc. are of similar size ($49.8M and $49.8M). LeonaBio, Inc. has the higher net margin (0.00% vs −1,030.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Caribou Biosciences, Inc. leads on 6 and LeonaBio, Inc. on 6.

Valuation

Metric CRBU LONA Biotechnology median
P/E n/m n/m 8.50
P/S 4.73 n/m 9.71
P/B 0.48 3.67 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.60 n/m 0.64
EV/Sales (6.46) n/m 9.21
Earnings yield (229.79%) (444.41%) (33.15%)
Free cash flow yield (279.78%) (50.22%) (25.50%)

Profitability

Metric CRBU LONA Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin (1,090.90%) 0.00% 0.00%
Net margin (1,030.42%) 0.00% 0.00%
Free cash flow margin (1,323.30%) 0.00% 0.00%
Return on equity (78.27%) (431.39%) (56.36%)
Return on assets (56.87%) (306.05%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRBU LONA Biotechnology median
Revenue growth (TTM) 10.02% — 6.02%
EPS growth (last fiscal year) 3.64% 1.98% 30.26%
Revenue growth, 5-year CAGR (2.03%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBU LONA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.49 7.01 4.72
Net debt to EBITDA 0.96 0.87 0.96

Dividend

Metric CRBU LONA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRBU LONA Biotechnology median
Market cap 49.82m 49.84m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack